Mon, June 6, 2022
Sun, June 5, 2022
Fri, June 3, 2022
Thu, June 2, 2022
Wed, June 1, 2022
Tue, May 31, 2022
Mon, May 30, 2022
Fri, May 27, 2022
Thu, May 26, 2022

Travis Steed Maintained (ABT) at Strong Buy and Held Target at $140 on, May 31st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-140-on-may-31st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Travis Steed of B of A Securities, Maintained "Abbott Laboratories" (ABT) at Strong Buy and Held Target at $140 on, May 31st, 2022.

Travis has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 1 agrees with Travis's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 5 analyists that currently disagree with Travis


  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 17th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $135 on, Thursday, April 21st, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $143 on, Thursday, April 21st, 2022
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy and Held Target at $114 on, Sunday, April 10th, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022

Publication Contributing Sources